相关实验视频

Updated: Mar 14, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

RG108-联白金(IV) 前药:提高有效性和降低耳毒性

Jiyong Wu^1,2,3, Jing Nie^1,2,3, Huina Wu³

¹Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong, P. R. China.

Chemistry (Weinheim an der Bergstrasse, Germany)

|March 13, 2026

概括

有RG108联体的新金 (IV) 前药显示出强大的抗瘤活性,并显著降低了耳毒性. 这些双重功能药物为克服化疗中听力损失副作用提供了一个有希望的策略.

科学领域:

药用化学医学化学
在瘤学瘤学.
耳毒性研究研究

背景情况:

基于的化疗药物是癌症治疗的重要手段,但会导致严重的副作用,如耳毒性.
耳毒性或听力损失是类药物的剂量限制性毒性,影响患者的生活质量.

研究的目的:

合成和评估新的 (IV) 预制药,旨在保持抗瘤疗效,同时减轻耳毒性.
研究新型前药物增强的抗瘤活性和保护作用背后的机制.

主要方法:

合成由西斯和氧沙衍生的单替代和二替代 (IV) 预制药,其中包含听力保护联体RG108.8.
在实验室中使用FaDu细胞中的IC50值对抗瘤活性进行评估.
专注于EZH2/SLC47A2调节轴的机制研究.
在体内评估耳毒性,包括耳毛细胞活力,听觉脑干响应值和耳形态.

主要成果:

化合物4显示出显著的抗瘤活性 (IC50=0.07±0.08μM在FadU细胞中).
增强的抗瘤作用与EZH2/SLC47A2调节轴有关.
(IV) 前药有效减轻了耳毒性,保持了耳结构和功能.

结论:

新型金(IV) 前药可以设计为具有强大的抗瘤活性和器官保护性质.
这些双重功能药物代表了一种有前途的治疗方法,以解决传统化疗的耳毒性限制.
这些发现为开发下一代基于的癌症疗法提供了框架,这些疗法具有更好的安全性.

关键词:

抗癌剂是一种抗癌剂.西斯普拉丁 (cisplatin) 是一种制剂.听力损失听力损失是什么医学无机化学医学无机化学金属药物毒品金属药物

更多相关视频

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

相关概念视频

Prodrugs

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...